Trailhead Biosystems Announces David Llewellyn, PhD, MBA, as Chief Executive Officer
BEACHWOOD, Ohio, May 20, 2025 /CNW/ -- Trailhead Biosystems Inc. (TrailBio.com), a biotechnology company pioneering the creation of iPSC-derived human cells at scale for drug discovery and cell therapy, is pleased to announce the appointment of David Llewellyn, PhD, MBA as its new Chief Executive Officer, and as a member of its Board of Directors. Dr. Llewellyn succeeds Jan Jensen, PhD, who has led the company as Chief Executive Officer and Chief Scientific Officer since its founding. Dr. Jensen will continue with Trailhead Biosystems as Chief Scientific Officer and Board member.
"We are pleased to welcome Dr. Llewellyn to the company," said Michael Kaufman, Chairman of the Board of Trailhead Biosystems. "David brings with him over 20 years of experience commercializing life science products. His strong scientific and business acumen will be invaluable as Trailhead continues to innovate and expand."
Dr. Jensen reflected on the transition, stating, "Trailhead Biosystems has reached an exciting inflection point, and bringing David Llewellyn on to the executive team marks the start of an ambitious new chapter. His expertise in life sciences and business strategy makes him the right leader to propel us onward, and I look forward to working alongside him to accelerate the commercialization of our groundbreaking technologies."
Dr. Llewellyn began his career at MethylGene Inc. as a Medicinal Chemist where he developed a wide range of novel DNA methyltransferase inhibitors to treat cancer. He later joined Aquinox Pharmaceuticals, where he was involved in a variety of different activities including business development, financing and operations. Most recently, Dr. Llewellyn worked with STEMCELL Technologies Inc., where he held several top executive roles including Senior Vice President of Business Operations, Chief Commercial Officer, and Chief Strategy Officer. David holds a BSc in Chemistry from the University of Northern British Columbia, a PhD in Organic Chemistry from McGill University, and an MBA in Strategic Management from the University of British Columbia.
"I am honored to step into the role of CEO and join the Board of Trailhead Biosystems," said Dr. Llewellyn. "Trailhead's proprietary High-Dimensional Design-of-Experiments Technology (HD-DoE®) is a groundbreaking approach for making differentiated induced pluripotent stem cells, and there is no question that it's going to play an important role advancing stem cell research."
Trailhead Biosystems is dedicated to revolutionizing medical research and the field of regenerative medicine by developing specialized, high-quality iPSC-derived human cells for drug discovery and cell-based therapies. Under Dr. Llewellyn's leadership, Trailhead plans to expand on its mission of advancing healthcare through scientific innovation with a strong commitment to commercial and scientific excellence.
For more information, please contact:Tim Mauk, Corporate CommunicationsTrailhead BiosystemsEmail: info@trailbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/trailhead-biosystems-announces-david-llewellyn-phd-mba-as-chief-executive-officer-302459593.html
SOURCE Trailhead Biosystems Inc
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/20/c8490.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
WebMD
39 minutes ago
- WebMD
Navigating Skincare: Keloids, Climate, and Consistency
As a child, the dermatologist was the doctor I visited most frequently. Between dark spots on my face, severely chapped lips, and dry skin during the winter, I was always being prescribed a new ointment or remedy to try. Today, the first two issues have been resolved thanks to healthier eating habits and finding the right skin care and lip products for me. However, I still deal with dry skin not only in the winter but throughout most of the year. I've noticed that my keloid scars, along with the surrounding areas, are particularly prone to dry skin. For those unfamiliar with keloids, they're a growth of extra scar tissue that happens where the skin has healed after an injury or surgical procedure. I've been dealing with them since I was in middle school, having developed a large one on the back of my earlobe following my ear piercing. My breast cancer treatment and surgeries introduced several more keloids into my life, including at the site of my chemo port, in the radiated area of my breast, and the largest one – a long scar across my back from one of my breast reconstruction surgeries. While they're not painful, they're often dry, itchy, and hard to reach in certain spots (like the scar on my back, which can be tricky to moisturize properly because of its location). I recently moved from Atlanta to Chicago, which has caused me to rethink my winter skin care routine, especially when it comes to my keloid-prone skin. The cold, dry air makes my scars even itchier and more dehydrated, so I've had to adjust my approach. I've found that layering an oil-based body lotion with a body oil helps my skin lock in moisture longer. Additionally, applying Vaseline to my keloids every morning and night has provided extra relief. My need for a tailored skin care routine isn't just about adapting to the colder months. It's a reminder of how I've had to advocate for my skin's unique needs throughout my health journey – from childhood to my breast cancer treatment. Many aspects of health care don't always consider the needs of people with melanin-rich skin, something I've learned time and time again. One example of this happened before starting radiation, when I was informed that the radiated area would turn darker, like a tan. However, what I experienced was nothing like a cute summer tan – my skin turned completely black and became very tender and painful. I realized early on that the standard skin care recommendations wouldn't work for my skin's needs, requiring me to look for alternatives. Taking proper care of my skin is a constant journey, especially when navigating different climates and changing seasons. I usually shop based on reviews, which has quickly taught me that what works for one person might not work for another, and that's OK. The key is to listen to your body, stay consistent, and adjust your routine to support your skin's unique needs. Whether it's layering oils during the winter or finding products that soothe and hydrate, prioritizing what works best for you is key – your skin will thank you for it.
Bloomberg
39 minutes ago
- Bloomberg
Uncertainty May Lead to 'Pothole' for Stocks: Seema Shah
"This is a tough environment for investors," Seema Shah, Principal Asset Management chief global strategist, says. Speaking on "Bloomberg Open Interest," Shah also says the Federal Reserve won't cut rates until at least the fourth quarter. (Source: Bloomberg)
Bloomberg
an hour ago
- Bloomberg
BlackRock, Goldman Scale Up Tax Trades in $3 Trillion SMA Boom
This year's stock market turbulence has punished ordinary investors. But for the wealthy, it's opened up fresh opportunities to convert equity swings into tax breaks — fueling a growing Wall Street business that turns volatility into a financial advantage. BlackRock Inc., Goldman Sachs Group Inc. and Morgan Stanley are among firms scaling up a strategy known as tax-loss harvesting, typically offered through customized portfolios called separately managed accounts. When markets drop, managers sell stocks trading below their purchase price to realize losses. Those losses offset gains elsewhere in a portfolio, reducing clients' tax liabilities while maintaining overall portfolio exposure.
